The New England journal of medicine, 2024-01, Vol.390 (2), p.107-117
- Healey, Jeff S.
- Lopes, Renato D.
- Granger, Christopher B.
- Alings, Marco
- Rivard, Lena
- McIntyre, William F.
- Atar, Dan
- Birnie, David H.
- Boriani, Giuseppe
- Camm, A. John
- Conen, David
- Erath, Julia W.
- Gold, Michael R.
- Hohnloser, Stefan H.
- Ip, John
- Kautzner, Josef
- Kutyifa, Valentina
- Linde, Cecilia
- Mabo, Philippe
- Mairesse, Georges
- Benezet Mazuecos, Juan
- Cosedis Nielsen, Jens
- Philippon, Francois
- Proietti, Marco
- Sticherling, Christian
- Wong, Jorge A.
- Wright, David J.
- Zarraga, Ignatius G.
- Coutts, Shelagh B.
- Kaplan, Andrew
- Pombo, Marta
- Ayala-Paredes, Felix
- Xu, Lizhen
- Simek, Kim
- Nevills, Sandra
- Mian, Rajibul
- Connolly, Stuart J.
2024
Details
- Autor(en) / Beteiligte
- Healey, Jeff S.
- Lopes, Renato D.
- Granger, Christopher B.
- Alings, Marco
- Rivard, Lena
- McIntyre, William F.
- Atar, Dan
- Birnie, David H.
- Boriani, Giuseppe
- Camm, A. John
- Conen, David
- Erath, Julia W.
- Gold, Michael R.
- Hohnloser, Stefan H.
- Ip, John
- Kautzner, Josef
- Kutyifa, Valentina
- Linde, Cecilia
- Mabo, Philippe
- Mairesse, Georges
- Benezet Mazuecos, Juan
- Cosedis Nielsen, Jens
- Philippon, Francois
- Proietti, Marco
- Sticherling, Christian
- Wong, Jorge A.
- Wright, David J.
- Zarraga, Ignatius G.
- Coutts, Shelagh B.
- Kaplan, Andrew
- Pombo, Marta
- Ayala-Paredes, Felix
- Xu, Lizhen
- Simek, Kim
- Nevills, Sandra
- Mian, Rajibul
- Connolly, Stuart J.
- Titel
- Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
- Ist Teil von
- The New England journal of medicine, 2024-01, Vol.390 (2), p.107-117
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2024
- Link zum Volltext
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In a randomized trial involving patients with subclinical (typically asymptomatic) atrial fibrillation, apixaban led to a lower risk of stroke or systemic embolism than aspirin but a higher risk of major bleeding.
- Sprache
- Englisch; Norwegisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa2310234Titel-ID: cdi_swepub_primary_oai_prod_swepub_kib_ki_se_237952132
- Format
- –
- Schlagworte
- Aged, Aged, 80 and over, Anticoagulants, Anticoagulants - adverse effects, Anticoagulants - therapeutic use, Anticoagulation, Arrhythmias, Aspirin, Aspirin - adverse effects, Aspirin - therapeutic use, Asymptomatic, Atrial Fibrillation - complications, Atrial Fibrillation - diagnosis, Bleeding, Canada, Cardiac arrhythmia, Cardiology, Clinical trials, Coagulation, Creatinine, Defibrillators, Double-Blind Method, Drug dosages, Embolism, Embolism - etiology, Embolism - prevention & control, Embolisms, Factor Xa Inhibitors - adverse effects, Factor Xa Inhibitors - therapeutic use, Female, Fibrillation, Hematology, Hemorrhage - chemically induced, Humans, Ischemia, Male, Medical research, Medicin och hälsovetenskap, Monitoring systems, Neurology, Neurosurgery, Oncology, Pacemakers, Patients, Pyridones - adverse effects, Statistical analysis, Stroke, Stroke - etiology, Stroke - prevention & control, Thromboembolism, Treatment Outcome